Form 4 for HCA HCA Healthcare
Accepted 2025-02-11 00:00:00 ET · period of report 2025-02-07 · accession 0000950170-25-018161 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-02-11 | 2025-02-07 | HCA | Berres Jennifer | SVP, Chief Human Res. Off | M - OptEx | $115.12 | +11.8K | 30.5K | +63% | +$1.36M |
| D | 2025-02-11 | 2025-02-07 | HCA | Berres Jennifer | SVP, Chief Human Res. Off | F - Tax | $322.05 | -6,747 | 23.8K | -22% | -$2.17M |
| DM | 2025-02-11 | 2025-02-07 | HCA | Berres Jennifer | SVP, Chief Human Res. Off | M - OptEx | $0.00 | -11.8K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-07 | M | A | 7,440 | $101.16 | 26,171 | D | — | — | |
| 2 | Common | Common Stock | 2025-02-07 | M | A | 4,340 | $139.06 | 30,511 | D | — | — | |
| 3 | Common | Common Stock | 2025-02-07 | F | D | 6,747 | $322.05 | 23,764 | D | — | — | |
| 4 | Derivative | Stock Appreciation Right | 2025-02-07 | M | D | 4,340 | $0.00 | 0 | D | $139.06 · — to 2029-01-30 | 4,340 Common Stock | (F2) The stock appreciation rights vested in four equal annual installments beginning on January 30, 2020. |
| 5 | Derivative | Stock Appreciation Right | 2025-02-07 | M | D | 7,440 | $0.00 | 0 | D | $101.16 · — to 2028-01-31 | 7,440 Common Stock | (F1) The stock appreciation rights vested in four equal annual installments beginning on January 31, 2019. |